- Market Capitalization, $K 77,690
- Shares Outstanding, K 21,285
- Annual Sales, $ 0 K
- Annual Income, $ -27,530 K
- 60-Month Beta N/A
- Price/Sales N/A
- Price/Cash Flow N/A
- Price/Book 1.05
|Period||Period Low||Period High||Performance|
| || |
-0.12 (-3.18%)since 08/24/21
| || |
-1.45 (-28.43%)since 06/24/21
Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of diseases of the retina and optic nerve, today announced...
Investors need to pay close attention to Graybug Vision (GRAY) stock based on the movements in the options market lately.
/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for VXRT, GRAY, JAGX, IBIO, and APTX.
"We greatly appreciate the profound level of support and trust from three global investors," said , PhD, Co-Founder, Chairman, and Chief Executive Officer. "With these proceeds, our goal is to build an...